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Abstract
A central challenge in host-pathogen systems biology is the elucidation of general, systems-level principles that distinguish
host-pathogen interactions from within-host interactions. Current analyses of host-pathogen and within-host protein-
protein interaction networks are largely limited by their resolution, treating proteins as nodes and interactions as edges.
Here, we construct a domain-resolved map of human-virus and within-human protein-protein interaction networks by
annotating protein interactions with high-coverage, high-accuracy, domain-centric interaction mechanisms: (1) domain-
domain interactions, in which a domain in one protein binds to a domain in a second protein, and (2) domain-motif
interactions, in which a domain in one protein binds to a short, linear peptide motif in a second protein. Analysis of these
domain-resolved networks reveals, for the first time, significant mechanistic differences between virus-human and within-
human interactions at the resolution of single domains. While human proteins tend to compete with each other for domain
binding sites by means of sequence similarity, viral proteins tend to compete with human proteins for domain binding sites
in the absence of sequence similarity. Independent of their previously established preference for targeting human protein
hubs, viral proteins also preferentially target human proteins containing linear motif-binding domains. Compared to human
proteins, viral proteins participate in more domain-motif interactions, target more unique linear motif-binding domains per
residue, and contain more unique linear motifs per residue. Together, these results suggest that viruses surmount genome
size constraints by convergently evolving multiple short linear motifs in order to effectively mimic, hijack, and manipulate
complex host processes for their survival. Our domain-resolved analyses reveal unique signatures of pleiotropy, economy,
and convergent evolution in viral-host interactions that are otherwise hidden in the traditional binary network, highlighting
the power and necessity of high-resolution approaches in host-pathogen systems biology.
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Introduction
Protein-protein interactions (PPIs) can be broadly classified into
two fundamentally different classes: those within the same species,
such as within-host PPIs, and those between different species, such
as host-pathogen PPIs. Are there general, systems-level principles
that distinguish host-pathogen PPIs (exogenous interactions) from
within-host PPIs (endogenous interactions)? Surprisingly, little is known
about the existence and nature of such global principles, in part
because they are not amenable to investigation by traditional
methods, which examine specific host-pathogen PPIs individually.
The most well-studied host-pathogen interaction systems are host-
virus interactions, and the combined results of decades of detailed
studies on specific host-virus interactions suggest that such global
principles may exist. Endogenous interactions among host proteins
are expected to be cooperative: proteins encoded within the same
genome interact with one another to carry out biological function
in a coordinated and synergistic fashion. On the contrary,
exogenous interactions between viral proteins and host proteins
are expected to be largely antagonistic: viruses physically
manipulate host cell machinery to perpetuate their genomes at
the host’s expense. In addition to hijacking host macromolecular
complexes to make new viral products, viruses are known to
modulate the host response to infection in order to escape
detection and prevent the host from interfering with viral
replication [1–3]. Many viral proteins directly compete with host
proteins for binding sites [4], and some even modify host proteins
chemically, e.g. marking them for degradation by the host’s own
machinery [5–7]. Despite providing such detailed information
about the molecular mechanisms and consequences of specific
exogenous interactions, traditional virology studies are highly
focused and thus are often unable to draw general conclusions
about the mechanisms governing exogenous interactions even
among closely related viruses. As a result, despite these detailed
studies on specific host-virus interaction systems, the overarching
principles that distinguish host-virus interactions from within-host
interactions have not yet been elucidated.
A systems biology approach is therefore essential in order to
obtain a global perspective on host-pathogen interactions. Recent
advances in high-throughput experimental and computational
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biology have enabled the reconstruction and analysis of large-scale
host-pathogen PPI networks [8–18]. These systematic studies have
successfully revealed global patterns in host-pathogen systems that
are otherwise inaccessible by the traditional reductionist approach,
which studies host-pathogen PPIs one at a time. For example,
global analyses have revealed that viral proteins have repeatedly
evolved to target host proteins central to the host PPI network
(e.g. hubs with many physical interaction partners) [8,11,19]. In
addition to targeting common host pathways regulating viral
infection and replication in general [11,20], different classes of
viruses also target host pathways uniquely involved in class-specific
mechanisms of infection and replication [20]. Despite these
advances, current host-pathogen systems biology approaches are
highly abstract and coarse-grained, treating proteins as nodes
and PPIs as edges; therefore, the insights generated by these
analyses are strongly limited in spatial and mechanistic resolution.
A high-resolution approach is needed to uncover more general
rules governing host-pathogen PPI networks [21].
One approach to increase resolution in PPI networks has been
to construct three-dimensional (3D) structural models to protein
interactions [22–25]. We recently applied this technique to build
an atomic-resolution map of human-virus and within-human PPI
networks by constructing 3D structural models of exogenous and
endogenous PPIs using homology modeling [4]. A direct
comparison between the resulting human-virus and within-human
structural interaction networks revealed systematic and significant
differences between exogenous and endogenous interactions that
are otherwise hidden in the binary PPI networks. For example, we
found that viral proteins preferentially bind to and mimic existing
endogenous interfaces on their human target proteins, rather than
creating entirely new interfaces. In addition, interface mimicry
tends to be achieved without structural similarity in the human-
virus PPI network as compared to the within-human PPI network.
Finally, endogenous interfaces mimicked by virus proteins tend
to evolve quickly, and mediate many endogenous interactions that
are transient and regulatory in function, as compared to generic
endogenous interfaces [4]. Although 3D structure information
can be used to interrogate host-pathogen interaction networks at
atomic resolution in a reasonably unbiased manner, coverage in
these analyses is limited by the number of high-quality 3D
homology models that can be built for endogenous and exogenous
interactions [26].
In this work, we probe high-resolution principles governing
exogenous and endogenous PPI networks using a domain-resolved
approach that annotates proteins with known domains, and PPIs
with known domain-centric interaction mechanisms (domain-
domain interactions and domain-motif interactions; Figure 1).
This domain-resolved network is of higher accuracy than the
binary PPI network, and of higher coverage than the 3D structural
interaction network. Although domain-based studies of host-
pathogen PPIs have been previously reported for specific
pathogens [27,28], a systematic, quantitative comparison between
exogenous and endogenous PPI networks at the level of domains
has never been attempted before. Domain-motif interactions
have been previously reported to be important in host-pathogen
interactions [29], but their prevalence in the global host-pathogen
interaction network remains unknown relative to the within-host
network [29]. Our global, domain-resolved map of human-virus
and within-human PPI networks enables, for the first time, the
discovery of novel systematic and statistically significant differences
between exogenous and endogenous PPIs in terms of domain
interaction usage. While two human proteins competing to bind
the same domain tend to have global sequence similarity, viral
proteins competing with human proteins do not. Viral proteins
Author Summary
The goal of host-pathogen systems biology is to examine
the complex interactions between species, such as those
between a virus and its host. Analysis of protein-protein
interaction (PPI) networks can identify general principles
that distinguish between within-species and between-
species interactions. However, PPI data are limited by their
low resolution, and cannot provide detailed information
about the physical mechanisms underlying interactions
between proteins. Using protein domain-based annotation
methods, we have constructed an integrated human-virus
PPI network which better highlights the mechanistic
differences between human-human and human-virus PPIs.
Our findings suggest that viral proteins use unique
strategies to interact with human proteins, a finding with
significant implications for pathogen research.
Figure 1. Domain-centric mechanisms of host-virus protein-protein interaction. (A) A domain-domain interaction (DDI) example [43]: a
cyclin domain-containing protein from Saimiriine herpesvirus 2 (red) targets a human CDK6 kinase domain (white). (B) A domain-motif interaction
(DMI) example [44]: human retinoblastoma-associated protein (white) contains a linear motif-binding (LMB) domain which recognizes the peptide
motif LxCxE (red) in the human papillomavirus E7 protein.
doi:10.1371/journal.ppat.1003778.g001
Domain-Resolved Human–Virus Interaction Networks
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preferentially target human proteins containing linear motif-
binding domains independent of their degree in the endogenous
network. In addition, viral proteins use linear motifs to mediate
protein-protein interactions more often than human proteins do.
Finally, viral proteins contain a higher density of linear motifs
than generic human proteins. Collectively, these observations
suggest that the exogenous network is very different from the
endogenous network in terms of domain interaction usage. While
the endogenous network evolves largely by gene duplication
followed by divergence, the exogenous network is dominated by
convergent evolution of domain-motif and domain-domain
interactions. Compared to human proteins, viral proteins tend to
convergently evolve and pack multiple linear motifs mediating
many biophysical interactions that are functionally diverse in order
to manipulate complex host processes. Together, these results
strongly support the utility of a domain-resolved approach for
interrogating host-pathogen interaction networks, and in par-
ticular for determining the general principles that distinguish
exogenous and endogenous interactions.
Results
A high-coverage, high-accuracy domain-resolved
human-virus interaction network
We constructed high-resolution human-virus (exogenous)
and within-human (endogenous) protein-protein interaction (PPI)
networks by annotating proteins and PPIs with known domain
information. We considered two major categories of domain-
centric interaction mechanisms: domain-domain interactions
(DDIs), in which a globular domain from one protein binds to a
globular domain from a second protein (Figure 1A), and domain-
motif interactions (DMIs), in which a linear motif-binding (LMB)
domain from one protein binds to a short, linear peptide motif in a
second protein (Figure 1B). Some PPIs can be annotated with both
DDI and DMI mechanisms.
The endogenous portion of our network contains 39,329 PPIs
among 9,870 human proteins, of which 48.7% can be assigned to
at least one of the two domain-centric mechanisms (Figure 2).
There are 8,277 DDIs mediated by 1,164 unique domain types
forming 3,209 unique types of interacting domain pairs. In
addition, there are 16,785 DMIs mediated by 554 unique LMB
domain types (Figure 2).
The exogenous portion of our network contains 1,670
interactions between 267 viral proteins and their 954 human
protein targets. The viral proteins represent 17 viral families and
7 Baltimore classes (Table S1) [30]. 30.5% of all exogenous
interactions can be assigned at least one domain-centric
interaction mechanism, which can be further divided into the
following five cases (Figure 2). (i) 30 exogenous DDIs involve a
human domain homolog present in a viral protein, presumably
due to horizontal gene transfer (Table S2). (ii) 110 exogenous
DDIs involve human domains interacting with virus-specific
domains. (iii) 443 exogenous DMIs are mediated by an LMB
domain-containing human protein binding to a viral protein with
the corresponding linear motif. (iv) 11 exogenous DMIs are
mediated by a viral protein containing a human-like LMB
domain binding to a human protein with the corresponding
linear motif (e.g. the SH2 and SH3 domain-containing Src
protein from Avian sarcoma virus, and the kinase domain-
containing BGLF4 protein from Epstein-Barr virus). (v) Exoge-
nous DMIs mediated by virus-specific LMB domains are only
just starting to be characterized [31], and are not represented in
our network.
Domain-resolved interactions are of high quality
Annotating exogenous and endogenous PPI networks with
domain-centric interaction mechanisms yields networks with
increased resolution compared to binary networks, while main-
taining high coverage. We annotated proteins with complete
taxonomic and Pfam domain information [32,33], and PPIs with
interacting domain information [34–36]. These annotated PPIs
are of higher quality than generic PPIs, as measured by the overlap
with a gold standard set of PPIs reported by at least two
independent publications (‘‘confirmed interactions’’). Specifically,
endogenous interactions annotated with domain-centric mecha-
nisms are 52% more likely to be confirmed than non-annotated
endogenous interactions (Figure 3), and exogenous interactions
annotated with domain-centric mechanisms are 28% more likely
to be confirmed than non-annotated exogenous interactions
(Figure 3). Hence, in addition to providing mechanistic insights,
annotation of endogenous and exogenous interactions with
domain interaction information raises our confidence in the
accuracy of the underlying interactions.
Figure 2. Coverage of human-virus protein-protein interaction network by domain-centric interaction mechanisms. Fractions of
endogenous and exogenous PPIs that can be assigned to different domain-centric interaction mechanisms (DDIs and DMIs). Each mechanism is
illustrated using the symbols at the left, with the percentage of interactions described by that mechanism given below. An interaction may be
described by more than one interaction mechanism.
doi:10.1371/journal.ppat.1003778.g002
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Binding site mimicry evolves differently in virus and host
proteins
In our previous work based on 3D structural models of
exogenous and endogenous interactions, we demonstrated that
viral proteins frequently bind to human target proteins at sites of
existing endogenous interfaces (‘‘interface mimicry’’) [4]. More-
over, compared to overlap among endogenous interfaces, exog-
enous-endogenous interface overlap was much less likely to involve
global structural similarity between the two proteins targeting the
same interface [4]. Here, we reexamined this result in the context
of our domain-resolved human-virus PPI network.
In the absence of 3D structural information, it is not possible to
determine if two proteins bind to the same interface on a third
protein. However, in our domain-resolved human-virus PPI
network, it is possible to determine if two proteins bind to the
same domain in the third protein (Figure 4A–C), which is a
prerequisite for interface mimicry. A similar approach has been
previously used in the yeast 3D structural interaction network to
distinguish between singlish-interface hub proteins, which mediate
mutually exclusive PPIs, and multi-interface hub proteins, which
mediate multiple simultaneous PPIs [22]. Among DDIs in the
endogenous network, of the 3,493 cases where two human
proteins bind to the same domain of a third human protein, 72%
are mediated by domains sharing significant sequence similarity
(Figure 4D). In contrast, among DDIs in the combined exogenous-
endogenous network, of the 46 cases where a viral protein and
a human protein bind to the same domain of another human
protein, only 24% are mediated by domains sharing significant
sequence similarity (Figure 4D). The results from these domain-
resolved analyses are consistent with our previous findings using
3D structural networks: viral proteins are significantly less likely
than human proteins to bind to the same domain of a human
target protein by means of global sequence similarity to an
endogenous binding partner (Fisher’s exact test, two-tailed
P,10210; Figure 4D).
Viruses tend to target LMB domain-containing human
proteins
Viruses have been known to use linear peptide motifs to target
endogenous LMB domains [21,29]; however, it is unknown how
prevalent this mechanism of interaction is. Here, we quantified
how frequently viral proteins target host proteins using a domain-
motif interaction mechanism. We examined the domain compo-
sition of human proteins targeted by viruses, and compared it with
the domain composition of generic human proteins in the network.
We found that human proteins targeted by viruses are significantly
enriched for LMB domains relative to generic human proteins
(Fold enrichment = 1.36; Fisher’s exact test, two-tailed P,10215;
Figure 5). With the exception of Orthomyxoviruses, the direction
Figure 3. Domain-resolved interactions are of high quality.
Endogenous (blue) and exogenous (red) PPIs that are supported by a
known DDI or DMI are enriched for confirmed interactions (i.e.,
interactions reported by at least two publications). Endogenous and
exogenous PPIs lacking the support of domain-centric mechanisms are
depleted for confirmed interactions. Error bars reflect the standard error
based on 1,000 rounds of bootstrap resampling.
doi:10.1371/journal.ppat.1003778.g003
Figure 4. Binding site mimicry evolves differently in virus and host proteins. Two proteins can participate in DDIs with a common target by
binding to: (A) different domains in the target; (B) the same domain in the target using different interaction domains; or, (C) the same domain in the
target using the same interaction domain. (D) Viral proteins are significantly less likely than human proteins to bind to the same domain of a human
protein by means of domain sequence similarity to an endogenous binding partner (Fisher’s exact test, two-tailed P,10210).
doi:10.1371/journal.ppat.1003778.g004
Domain-Resolved Human–Virus Interaction Networks
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of this trend holds for exogenous interactions from all major viral
families in the network, and cannot be attributed to a specific type
of virus (Figure 5). In contrast, the difference in enrichment
for non-LMB domains between human proteins targeted by
viruses and generic human proteins is only marginally significant
(Fold enrichment = 0.96; P=0.012; Figure 5), suggesting that the
observed enrichment for LMB domains among human proteins
targeted by viruses is not a simple result of superior domain
annotation among these proteins.
Preferential targeting of LMB domains by viruses is
independent of host protein degree
Previous work has revealed a tendency for viral proteins to
target host protein hubs [11,27,28]. Because LMB domains
recognize small peptide motifs which may occur in many proteins,
we expect LMB domain-containing human proteins to participate
in more endogenous interactions than proteins without LMB
domains, and hence be more hub-like. Indeed, the average LMB
domain-containing human protein in our network participates in
10.5 endogenous interactions, while the average LMB domain-free
protein participates in only 6.4 endogenous interactions. As a
result, our finding that viruses tend to target LMB domain-
containing proteins may be confounded by the viral preference for
targeting hub proteins.
We examined the effects of endogenous degree on the
relationship between a human protein containing an LMB do-
main and the likelihood of that protein being a viral target. We
stratified human proteins according to endogenous degree and
then compared the probability of being a viral target among
proteins with and without LMB domains (Figure 6). Consistent
with previous findings that viruses target host protein hubs, we
observe that the probability of being a viral target increases with
increasing endogenous degree, and that this trend holds for both
LMB domain-containing proteins and LMB domain-free proteins
(Figure 6). More importantly, for a fixed endogenous degree,
LMB domain-containing human proteins are more likely to be
targeted by viruses than human proteins without LMB domains
(Figure 6). This finding suggests that viruses preferentially target
LMB domain-containing human proteins independent of their
higher average degree.
To quantify the statistical significance of this assertion, we
measured concordance between (i) having an LMB domain and
(ii) being a viral target, among pairs of human proteins with the
same degree. We picked a pair of proteins with the same degree
in which one had an LMB domain while the other did not, and
considered the pair concordant if the LMB domain-containing
protein was a viral target whereas the LMB domain-free protein
was not, and discordant if the LMB domain-containing protein was
not a viral target whereas the LMB domain-free protein was. We
observed a strong preference for concordant protein pairs over
discordant protein pairs (58% concordant versus 42% discordant),
favoring a degree-independent association between LMB domain-
containing proteins and viral targets. The degree-independent
association between a human protein containing an LMB domain
and being a viral target is statistically significant (one-tailed
P=0.006; Figure 6), as calculated by a degree-preserving random
permutation of LMB domain and viral target annotations among
sets of human proteins.
Figure 5. Viruses tend to target human proteins containing
linear motif-binding (LMB) domains. We compared domain
composition of generic human proteins in the endogenous network
(blue) to human proteins targeted by viruses (‘‘viral targets’’, red). The
vertical axis indicates the fraction of proteins in a group containing LMB
domains; the horizontal axis indicates the fraction of proteins
containing non-LMB domains. Relative to generic human proteins,
human proteins targeted by viruses are significantly more likely to
contain an LMB domain (vertical axis; Fisher’s exact test, two-tailed
P,10215), and are slightly less likely to contain non-LMB domains
(horizontal axis; P= 0.012).
doi:10.1371/journal.ppat.1003778.g005
Figure 6. Preferential targeting of LMB domains by viruses is
independent of host protein degree. We partitioned human
proteins into LMB domain-containing proteins (filled green points), and
LMB domain-free proteins (open black points). We further divided
proteins according to endogenous degree. 92% of all human proteins in
the network fall into one of the degree 1–20 bins; each bin contains at
least 20 proteins. The probability of being a viral target increases with
degree for both LMB domain-containing and LMB domain-free proteins.
For a given degree, LMB domain-containing proteins are more likely to
be viral targets than LMB domain-free proteins.
doi:10.1371/journal.ppat.1003778.g006
Domain-Resolved Human–Virus Interaction Networks
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Viral proteins have a higher fraction of domain-motif
interactions than human proteins
The results of the previous section establish that viruses tend to
preferentially target human proteins containing LMB domains by
comparing properties of human proteins targeted by viruses
against all other human proteins. Next, we determined if the viral
preference for targeting LMB domain-containing proteins also
holds at the level of PPIs, when comparing the fraction of domain-
motif interactions (DMIs) between viral proteins and human
proteins.
We observed that viral proteins have higher fraction of DMIs
out of total number of PPIs per protein than human proteins
(permutation test, two-tailed P=0.047; Figure 7A). To ensure this
trend was not due to superior annotation in either the endogenous
or exogenous dataset, we repeated the analyses on confirmed
interactions and observed the same trend (P=0.018; Figure 7B).
This result suggests that although the endogenous network
contains more proteins and PPIs and has a higher fraction of
domain annotation than the exogenous network (Figure 2), viral
proteins are more likely on average than human proteins to
interact using a domain-motif interface (Figure 7).
Viral proteins target LMB domains at greater density than
human proteins
We next examined whether viral preference for targeting LMB
domain-containing proteins is reflected in elevated linear motif
occurrence in viral proteins as compared to human proteins. We
determined density of linear motifs and LMB domains targeted
per protein, rather than directly comparing the total number of
linear motifs and LMB domains targeted per protein, to account
for the large difference in protein size between viral and human
proteins: within our network, the median viral protein length (306
residues) is 34% smaller than the median human protein length
(464 residues).
We first calculated the density of unique LMB domains targe-
ted per residue for viral proteins and human proteins. We
found that viral proteins target a greater variety of unique LMB
domains per residue than human proteins (permutation test, two-
tailed P=0.012; Figure 8A). This calculation directly compares
the properties of experimentally determined endogenous and
exogenous PPIs, and may be confounded by methodological
differences in mapping endogenous versus exogenous interactions:
only 22% of endogenous interactions are reported by small-scale
experiments (reporting fewer than 100 interactions), whereas as
many as 73% of exogenous interactions are reported by small-
scale experiments. To ensure that the aforementioned trend
observed in our network cannot be explained by this difference
in methodology, we repeated the analyses on a host-virus PPI
network built from the previously published ‘‘HI-2005’’ and
‘‘VirHost’’ interactome datasets, which were generated using
the same methodology [37,38], and observed the same trend
(P=0.049; Figure 8A). This analysis supports our earlier con-
clusion that viral proteins interact with a greater variety of distinct
LMB domains on a per residue basis than human proteins.
Our observation that viral proteins target more LMB domains
per residue than human proteins may still be confounded by subtle
differences in experimental procedures for mapping endogenous
versus exogenous interactomes. To control for such differences,
we calculated the density of linear motif types per residue for
each viral and human protein, regardless of whether the motifs
were used to mediate known interactions. This measure is
interactome-independent, and thus is free of any procedural
biases in experimental interactome maps. Consistent with our
previous findings, we found that viral proteins have significantly
more unique linear motif types per residue than human proteins
(P,0.001; Figure 8B). These results indicate that in addition
to preferentially targeting LMB domain-containing proteins
(Figures 5 and 6), viral proteins are more likely to target a greater
variety of unique LMB domains per residue than human proteins
(Figure 7), and have a higher density of unique linear motifs than
human proteins (Figure 8).
Discussion
We constructed a domain-resolved map of host-virus and
within-host protein-protein interaction (PPI) networks to probe
general, systems-level principles that distinguish host-pathogen,
exogenous PPIs from within-host, endogenous PPIs. Annotation
of proteins and interactions with known domain information
yields a domain-resolved network with higher resolution and
quality than the binary PPI network, and higher coverage than the
Figure 7. Viral proteins have a higher fraction of domain-motif interactions (DMIs) than human proteins. Fraction of DMIs out of the
total number of interactions per protein tend to be higher in viral proteins (red) than human proteins (blue) in (A) all interactions in the network
(permutation test, two-tailed P= 0.047), and (B) confirmed interactions (P= 0.018). Error bars reflect the standard error.
doi:10.1371/journal.ppat.1003778.g007
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3D structural interaction network. Classification of endogenous
and exogenous PPIs into domain-domain interactions (DDIs) and
domain-motif interactions (DMIs) reveals global differences in
domain interaction patterns between host-pathogen and within-
host networks that are otherwise hidden in traditional binary PPI
networks. While our domain-centric annotations reduce the rate of
false positives in PPI networks, additional potential limitations
include false negatives, incomplete annotation, and methodolog-
ical biases. In this work, we have minimized the effects of such
incompleteness and biases by carefully controlling for them when
performing systematic comparisons between exogenous and
endogenous networks. A potentially more significant limitation is
investigator bias: most host-pathogen studies are conducted on
clinically significant human pathogens, such as HIV. Despite this
investigator bias, our exogenous network represents a wide variety
of viral families (Table S1). We emphasize that our comparisons
and contrasts between exogenous and endogenous PPIs are
carried out within our domain-resolved interaction networks,
and therefore our conclusions should be minimally confounded by
systematic biases inherent in a domain-resolved approach.
Our analyses reveal systematic, mechanistic differences between
exogenous and endogenous interactions. The most pronounced of
these differences is the tendency for viruses to mimic human
interactions by means of convergent evolution. We find that viral
proteins and human proteins tend to target the same domain of
another human protein without any shared sequence similarity,
extending the results of our previous work using 3D structural
interaction networks [4]. In addition, we demonstrate for the first
time that viral proteins are more likely than human proteins to
mediate interactions using short linear motifs, which can easily
arise by convergent evolution due to their small size and minimal
genomic constraints. These observations support the hypothesis
that viral proteins tend to convergently evolve mechanisms to
mimic existing endogenous binding interfaces. In addition, viral
proteins are more economical and functionally more pleiotropic
than human proteins in that viral proteins target more LMB
domain-containing proteins, and also target more unique LMB
domains per residue. Furthermore, we found that viral proteins
contain more unique linear motif types per residue. Given the
knowledge that linear motifs in disordered regions tend to be
conserved and are more likely to be the target of binding by LMB
domains [39], we further investigated whether or not viral proteins
are more disordered than human proteins. Indeed, we find that
viral proteins are enriched for disorder-promoting residues [40]
relative to human proteins (Student’s t-test, two-tailed P,0.0001).
Additionally, considering only motifs in ‘‘disordered regions’’ (a
region 610 residues around a motif, containing .60% disorder-
promoting residues [40]), we observe that viral proteins continue
to have higher density of unique linear motif types per residue than
human proteins do (permutation test, two-tailed P,0.05).
Our results demonstrate that viral proteins and virus-host PPIs
are in general very different from host proteins and within-host
PPIs: viral proteins are small, complex, multifunctional polypep-
tides which can mediate multiple host-virus interactions, typically
using the highly economical and highly pleiotropic method of
domain-motif interactions largely through convergent evolution.
These signatures of pleiotropy, economy, and convergent evolu-
tion in the virus-host PPI network are a direct consequence of the
intense selection pressure on viruses to establish and maintain,
with very limited genomic resources at their disposal, extensive
and effective physical interactions with the host necessary for their
survival. These global trends are applicable in general to viral
proteins and exogenous interactions, and do not reflect a bias in a
specific viral type, nor in a specific methodology for determining
PPIs. Our results suggest that annotating viral proteins with
domain-centric interaction mechanisms, especially by scanning
viral protein sequences for linear motifs, can provide a novel
approach to identifying host protein interaction partners for study.
It may also be possible to use this domain-centric annotation
approach to identify therapeutic treatments based on competition
for motif binding sites. Thus, our study highlights the importance
of a high-resolution, domain-resolved approach to host-pathogen
network biology for revealing general mechanistic principles
governing host-pathogen interactions.
Methods
Assembling endogenous and exogenous protein-protein
interaction data
We collected reports of endogenous (human-human) protein-
protein interactions (PPIs) from the IntAct database, and reports
of exogenous (human-virus) PPIs from the IntAct and VirusMINT
databases [41,42]. We discarded PPIs with missing protein
sequence information in UniProt [33]. Exogenous PPIs were
Figure 8. Viral proteins target LMB domains at greater density than human proteins. Viral proteins (red) target significantly more unique
LMB domains per residue than human proteins (blue) in (A) all interactions in the network (permutation test, two-tailed P=0.012), and an
independently generated human-virus PPI network [37,38] (P= 0.049). (B) Viral proteins also have significantly more unique LMB motif types per
residue than human proteins (P,0.001). Error bars reflect the standard error.
doi:10.1371/journal.ppat.1003778.g008
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further filtered to exclude (i) virus species that do not normally
target mammalian hosts, and (ii) deltaviruses, which (as subviral
satellites) cannot infect a host without co-infection by another
virus. The viral proteins represent 17 viral families and all
Baltimore classes [30].
Annotating protein-protein interactions with domains
and interaction mechanisms
We assigned Pfam domains to the human and viral proteins in
our networks using the Pfam batch search utility, subject to an E-
value cutoff of 1022 [32]. To avoid misclassifying proviral
fragments in the human proteome as native human domains, we
removed human proteins from the analysis if they were annotated
as viral fragments or polyproteins in Uniprot. Using protein
sequence and domain information, we then assigned putative
interaction mechanisms to endogenous and exogenous PPIs in our
dataset. We classified PPIs as domain-domain interactions (DDIs)
if a domain in the first protein was known or predicted to interact
with a domain in the second protein. Pairs of putative interacting
domains were assembled from the DOMINE database [36], which
integrates results from a variety of DDI curation and prediction
studies. In addition, we classified PPIs as domain-motif interac-
tions (DMIs) if one of the proteins contained a putative linear
motif-binding (LMB) domain and the second protein contained a
linear motif recognized by that LMB domain. We utilized
predicted domain-motif associations from Neduva et al. [35] and
manually curated domain-motif associations from the database of
Eukaryotic Linear Motifs (ELM) [34]. Motifs in these datasets take
the form of regular expressions which can be searched directly
against an amino acid sequence using standard pattern matching
tools.
Comparison of datasets and statistical analyses
To assess the quality of the endogenous and exogenous
networks, we compared them individually against a gold standard
set of endogenous and exogenous PPIs; these subsets of
interactions were constructed by querying for interactions that
were reported by at least two independent publications.
We measured concordance between having an LMB domain
and being a viral target by picking pairs of human proteins with
the same degree in which one had an LMB domain while the
other did not. The protein pair was concordant if the LMB domain-
containing protein was a viral target and the LMB domain-free
protein was not a viral target. Conversely, the protein pair was
discordant if the LMB domain-containing protein was not a viral
target and the LMB domain-free protein was a viral target. All
other protein pairs were considered to be non-informative. To
evaluate the statistical significance of this test, we completed 1,000
repetitions of random permutation of the LMB domain and viral
target annotations among sets of human proteins with the same
endogenous degree and repeated our procedure.
For permutation-based comparisons of virus and human
proteins, we first compute the mean of each group and then
evaluate the difference between these means. To evaluate if such a
difference is likely to arise at random, we repeatedly permute the
‘‘virus’’ and ‘‘human’’ protein labels and then calculate the
difference in the means of the newly randomized groups. Over a
large number of trials (e.g. 1000), the fraction of permutations in
which the random difference is at least as large as the observed
difference approximates the probability of observing such a
difference at random (p-value), and serves as a measure of the
statistical significance of the observed measurement.
Supporting Information
Table S1 This table lists the number of unique proteins and total
number of interactions reported for each viral family found in the
network, as annotated by the 2011 release of the International
Committee on Taxonomy of Viruses.
(XLSX)
Table S2 This table lists the 17 unique human domains that
are observed in viral proteins to mediate 30 domain-domain
interactions with human proteins.
(XLSX)
Table S3 This table lists the endogenous domain-resolved PPIs.
Included in the table are UniProt IDs, protein descriptions, and
species annotation for the interacting protein pair. We also provide
the classification of domain-centric interaction mechanism: (1) a
human protein with a human domain binding to a second human
protein with a human domain (‘‘Human Domain : Human
Domain’’); and, (2) a human protein containing a human linear
motif-binding domain, binding to a human protein containing the
corresponding motif (‘‘(Human Domain : Motif) OR (Motif :
Human Domain)’’). Interacting domains or domain-motif pairs
are separated by a colon (:). If a protein has more than one pair of
interacting domains or domain-motifs, they are separated by a
vertical bar (|). Domains are listed by their Pfam annotation ID,
and motifs are listed as a searchable regular expression.
(XLSX)
Table S4 This table lists the exogenous domain-resolved PPIs.
Proteins are listed with human proteins followed by viral proteins,
with UniProt ID, protein description, and species annotation for
each protein. We have included the classification of domain-
centric interaction mechanism: (1) a human protein with a human
domain binding to a viral protein with a human domain (‘‘Human
Domain : Human Domain’’); (2) a human protein with a human
domain binding to a viral protein with a viral domain (‘‘Human
Domain : Virus Domain’’); (3) a human protein containing a
human linear motif-binding domain, binding to a viral protein
containing the corresponding motif (‘‘Human Linear Motif-
Binding Domain : Virus Motif’’); and, (4) a viral protein containing
a human linear motif binding domain, binding to a human protein
with the corresponding motif (‘‘Human Motif : Human Linear
Motif-Binding Domain’’). Interacting domains or domain-motif
pairs are separated by a colon (:). If a protein has more than one
pair of interacting domains or domain-motifs, they are separated
by a vertical bar (|). Domains are listed by their Pfam annotation
ID, and motifs are listed as a searchable regular expression.
(XLSX)
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